L A Sumerel
- Molecular Biology
- Genetics top 5%
- Immunology top 10%
- Oncology top 10%
- Infectious Diseases top 10%
- Co-authors
- David T. CurielAlbert F. LoBuglioJoanne T. DouglasR M ConryM. WrightDelicia CareyD L BarlowFrosty Loechel
- Topics
- Virus-based gene therapy research (4 papers)RNA Interference and Gene Delivery (4 papers)CAR-T cell therapy research (3 papers)
- Cited by
- GeneticsImmunologyBiotechnology
- Partner nations
- United StatesFrance
In The Last Decade
L A Sumerel
9 papers receiving 885 citations
Peers
Comparison fields: 5 of 61
- Molecular Biology 657
- Genetics 489
- Immunology 323
- Oncology 316
- Infectious Diseases 128
Countries citing papers authored by L A Sumerel
This map shows the geographic impact of L A Sumerel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L A Sumerel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L A Sumerel more than expected).
Fields of papers citing papers by L A Sumerel
This network shows the impact of papers produced by L A Sumerel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L A Sumerel. The network helps show where L A Sumerel may publish in the future.
Co-authorship network of co-authors of L A Sumerel
This figure shows the co-authorship network connecting the top 25 collaborators of L A Sumerel. A scholar is included among the top collaborators of L A Sumerel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L A Sumerel. L A Sumerel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 71 | |
| 3 | 118 | |
| 4 | Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors. | 145 |
| 5 | A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. | 95 |
| 6 | 80 | |
| 7 | A carcinoembryonic antigen polynucleotide vaccine for human clinical use. | 52 |
| 8 | Characterization of a messenger RNA polynucleotide vaccine vector. | 253 |
| 9 | Immune response to a carcinoembryonic antigen polynucleotide vaccine. | 96 |
| 10 | 1 |
About L A Sumerel
L A Sumerel is a scholar working on Oncology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 10 papers that have together received 919 indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), RNA Interference and Gene Delivery (4 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Genetics (489 citations), Immunology (323 citations) and Biotechnology (108 citations). L A Sumerel has collaborated with scholars based in United States and France. Frequent co-authors include David T. Curiel, Albert F. LoBuglio, Joanne T. Douglas, R M Conry, M. Wright, Delicia Carey, D L Barlow, Frosty Loechel, Susan E. Moore and Richard J. Benjamin. Their work appears in journals such as Nucleic Acids Research, British Journal of Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.